SCHEMBL28980313

SCHEMBL28980313

NC(=O)OCCOc1c(Cl)nc(Cl)nc1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.35
▸ CHRM2 P08172 2/20 0.33
▸ CHRM4 P08173 2/20 0.33
▸ CHRM5 P08912 2/20 0.33
▸ CHRM1 P11229 2/20 0.33
▸ CHRM3 P20309 2/20 0.33
▸ CHRNB2 P17787 2/20 0.33
▸ CHRNA4 P43681 2/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ CHRNA7 P36544 1/20 0.33
▸ CYP1A2 P05177 1/20 0.31
▸ PDCD1 Q15116 1/20 0.30
▸ CD274 Q9NZQ7 1/20 0.30
▸ ALOX15 P16050 1/20 0.30
▸ PLAU P00749 1/20 0.30
▸ GLA P06280 1/20 0.30
▸ CHRNB4 P30926 1/20 0.30
▸ CHRNA3 P32297 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16796041 0.75 ALOX15 (0.35) LMNACHRM2CHRM4CHRM5CHRM1
SCHEMBL27145902 0.73 LMNA (0.35) LMNACHRM2CHRM4CHRM5CHRM1
SCHEMBL24554756 0.72 PLAU (0.39) TSHRALOX15PLAU
Trifluoroacetic Acid SCHEMBL29109271 0.70 PLAU (0.43) PLAU
SCHEMBL29109244 0.69 KDM4E (0.30) —
SCHEMBL29109245 0.69 KDM4E (0.30) —
SCHEMBL2547540 0.68 LMNA (0.57) LMNACHRM2CHRM4CHRM5CHRM1
SCHEMBL15496427 0.67 KDM4E (0.43) TSHRCYP2C19CYP1A2
SCHEMBL30525718 0.66 LMNA (0.62) LMNACHRM2CHRM4CHRM5CHRM1
SCHEMBL11343033 0.65 LMNA (0.35) LMNATSHRALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116848125-A H4 antagonist compounds 赫帕雷斯治疗有限公司 2023-10-03 — — CN disclosed
CN-115925721-A Pyrimidone tricyclic derivative, preparation method, pharmaceutical composition and application thereof 上海赛默罗生物科技有限公司 2023-04-07 — — CN disclosed
Send feedback